A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer

Stopped early

Conditions studied: Small Cell Lung Cancer

In brief

The purpose of this study is to collect samples to evaluate the ProGRP and NSE assays independently as aids for monitoring the course of disease and therapy in subjects diagnosed with SCLC.

Key facts

Study ID

NCT01591512

Run by

Fujirebio Diagnostics, Inc.

People needed

4

Starts

2011-05-01

Expected to finish

2012-07-01

Last updated by the study team

2015-03-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18
• Confirmed diagnosis of SCLC or mixed SCLC/non-SCLC per histopathology results
• Scheduled to undergo first-, second- or third-line treatment for SCLC, including chemotherapy, chemotherapy + radiation therapy, or combined concurrent chemoradiotherapy.
• Able to understand and willing to provide Informed Consent

You may not qualify if…

• No diagnosis of SCLC
• Not scheduled to undergo treatment for the diagnosis of SCLC
• Unable to provide Informed Consent

Where it is running

• Kelly Family Medical Center, PC — Eastpointe, Michigan, United States
• St.Louis Cancer Care, LLP — Bridgeton, Missouri, United States
• Heartland Regional Medical Center — Saint Joseph, Missouri, United States
• Hematology Oncology Consultants, Inc. — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.